Loading…
Defining CTL immunotherapy candidates against replication-competent and defective HIV
Saved in:
Published in: | Journal of the International AIDS Society 2021-07, Vol.24 (S4), p.6 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | S4 |
container_start_page | 6 |
container_title | Journal of the International AIDS Society |
container_volume | 24 |
creator | Lee, E Horsburgh, B Schlub, T Milush, J Hoh, R Deeks, S Palmer, S |
description | |
doi_str_mv | 10.1002/jia2.25755 |
format | article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A672359349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A672359349</galeid><sourcerecordid>A672359349</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1369-2356c590c805e5fdf7b0ea33b02e3734625a8a2503adde06d752e34afd1e43c33</originalsourceid><addsrcrecordid>eNptkE9LAzEQxYMoWKsXP0FA8LY1m2yyu8dS_7Sw4KX1WqbJZJuymy1NKvjtjeihQpnDDDO_92AeIfc5m-SM8aedAz7hspTygozyUlYZV5JfnszX5CaEHWOKV0U9IqtntM4739LZsqGu749-iFs8wP6LavDGGYgYKLTgfIj0gPvOaYhu8Jke-j1G9JEmjhq0qKP7RDpffNySKwtdwLu_Piar15flbJ4172-L2bTJ2lyoOuNCKi1rpismUVpjyw1DEGLDOIpSFIpLqIBLJsAYZMqUMh0KsCbHQmghxuTh17eFDtfO2yEeQPcu6PVUlcm-FkWdqOwM1aJPb3aDTwGk9T9-coZPZbB3-qzg8USwRejiNgzd8SemcAp-A-Pifhg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Defining CTL immunotherapy candidates against replication-competent and defective HIV</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Lee, E ; Horsburgh, B ; Schlub, T ; Milush, J ; Hoh, R ; Deeks, S ; Palmer, S</creator><creatorcontrib>Lee, E ; Horsburgh, B ; Schlub, T ; Milush, J ; Hoh, R ; Deeks, S ; Palmer, S</creatorcontrib><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.1002/jia2.25755</identifier><language>eng</language><publisher>John Wiley & Sons, Inc</publisher><subject>Care and treatment ; CD8 lymphocytes ; Development and progression ; Genetic aspects ; Health aspects ; Histocompatibility antigens ; HIV infection ; HLA histocompatibility antigens ; Immunotherapy ; Methods ; Patient outcomes</subject><ispartof>Journal of the International AIDS Society, 2021-07, Vol.24 (S4), p.6</ispartof><rights>COPYRIGHT 2021 John Wiley & Sons, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Lee, E</creatorcontrib><creatorcontrib>Horsburgh, B</creatorcontrib><creatorcontrib>Schlub, T</creatorcontrib><creatorcontrib>Milush, J</creatorcontrib><creatorcontrib>Hoh, R</creatorcontrib><creatorcontrib>Deeks, S</creatorcontrib><creatorcontrib>Palmer, S</creatorcontrib><title>Defining CTL immunotherapy candidates against replication-competent and defective HIV</title><title>Journal of the International AIDS Society</title><subject>Care and treatment</subject><subject>CD8 lymphocytes</subject><subject>Development and progression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Histocompatibility antigens</subject><subject>HIV infection</subject><subject>HLA histocompatibility antigens</subject><subject>Immunotherapy</subject><subject>Methods</subject><subject>Patient outcomes</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptkE9LAzEQxYMoWKsXP0FA8LY1m2yyu8dS_7Sw4KX1WqbJZJuymy1NKvjtjeihQpnDDDO_92AeIfc5m-SM8aedAz7hspTygozyUlYZV5JfnszX5CaEHWOKV0U9IqtntM4739LZsqGu749-iFs8wP6LavDGGYgYKLTgfIj0gPvOaYhu8Jke-j1G9JEmjhq0qKP7RDpffNySKwtdwLu_Piar15flbJ4172-L2bTJ2lyoOuNCKi1rpismUVpjyw1DEGLDOIpSFIpLqIBLJsAYZMqUMh0KsCbHQmghxuTh17eFDtfO2yEeQPcu6PVUlcm-FkWdqOwM1aJPb3aDTwGk9T9-coZPZbB3-qzg8USwRejiNgzd8SemcAp-A-Pifhg</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Lee, E</creator><creator>Horsburgh, B</creator><creator>Schlub, T</creator><creator>Milush, J</creator><creator>Hoh, R</creator><creator>Deeks, S</creator><creator>Palmer, S</creator><general>John Wiley & Sons, Inc</general><scope/></search><sort><creationdate>20210701</creationdate><title>Defining CTL immunotherapy candidates against replication-competent and defective HIV</title><author>Lee, E ; Horsburgh, B ; Schlub, T ; Milush, J ; Hoh, R ; Deeks, S ; Palmer, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1369-2356c590c805e5fdf7b0ea33b02e3734625a8a2503adde06d752e34afd1e43c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Care and treatment</topic><topic>CD8 lymphocytes</topic><topic>Development and progression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Histocompatibility antigens</topic><topic>HIV infection</topic><topic>HLA histocompatibility antigens</topic><topic>Immunotherapy</topic><topic>Methods</topic><topic>Patient outcomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, E</creatorcontrib><creatorcontrib>Horsburgh, B</creatorcontrib><creatorcontrib>Schlub, T</creatorcontrib><creatorcontrib>Milush, J</creatorcontrib><creatorcontrib>Hoh, R</creatorcontrib><creatorcontrib>Deeks, S</creatorcontrib><creatorcontrib>Palmer, S</creatorcontrib><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, E</au><au>Horsburgh, B</au><au>Schlub, T</au><au>Milush, J</au><au>Hoh, R</au><au>Deeks, S</au><au>Palmer, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining CTL immunotherapy candidates against replication-competent and defective HIV</atitle><jtitle>Journal of the International AIDS Society</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>24</volume><issue>S4</issue><spage>6</spage><pages>6-</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><pub>John Wiley & Sons, Inc</pub><doi>10.1002/jia2.25755</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1758-2652 |
ispartof | Journal of the International AIDS Society, 2021-07, Vol.24 (S4), p.6 |
issn | 1758-2652 1758-2652 |
language | eng |
recordid | cdi_gale_infotracmisc_A672359349 |
source | Wiley-Blackwell Open Access Collection; Publicly Available Content Database; PubMed Central |
subjects | Care and treatment CD8 lymphocytes Development and progression Genetic aspects Health aspects Histocompatibility antigens HIV infection HLA histocompatibility antigens Immunotherapy Methods Patient outcomes |
title | Defining CTL immunotherapy candidates against replication-competent and defective HIV |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A16%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20CTL%20immunotherapy%20candidates%20against%20replication-competent%20and%20defective%20HIV&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Lee,%20E&rft.date=2021-07-01&rft.volume=24&rft.issue=S4&rft.spage=6&rft.pages=6-&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.1002/jia2.25755&rft_dat=%3Cgale%3EA672359349%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g1369-2356c590c805e5fdf7b0ea33b02e3734625a8a2503adde06d752e34afd1e43c33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A672359349&rfr_iscdi=true |